These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 22517028)
21. Subcutaneous concentrations following topical iontophoretic delivery of diclofenac. Kasha PC; Anderson CR; Morris RL; Sembrowich WL; Chaturvedula A; Banga AK Drug Discov Ther; 2012 Oct; 6(5):256-62. PubMed ID: 23229146 [TBL] [Abstract][Full Text] [Related]
22. In silico prediction of percutaneous absorption and disposition kinetics of chemicals. Chen L; Han L; Saib O; Lian G Pharm Res; 2015 May; 32(5):1779-93. PubMed ID: 25407547 [TBL] [Abstract][Full Text] [Related]
23. Diclofenac concentrations in defined tissue layers after topical administration. Müller M; Mascher H; Kikuta C; Schäfer S; Brunner M; Dorner G; Eichler HG Clin Pharmacol Ther; 1997 Sep; 62(3):293-9. PubMed ID: 9333105 [TBL] [Abstract][Full Text] [Related]
24. In vivo determination of the diclofenac skin reservoir: comparison between passive, occlusive, and iontophoretic application. Clijsen R; Baeyens JP; Barel AO; Clarys P Drug Des Devel Ther; 2015; 9():835-40. PubMed ID: 25709408 [TBL] [Abstract][Full Text] [Related]
25. In silico models to predict dermal absorption from complex agrochemical formulations. Guth K; Riviere JE; Brooks JD; Dammann M; Fabian E; van Ravenzwaay B; Schäfer-Korting M; Landsiedel R SAR QSAR Environ Res; 2014; 25(7):565-88. PubMed ID: 24905588 [TBL] [Abstract][Full Text] [Related]
26. Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route. Jain S; Patel N; Madan P; Lin S Pharm Dev Technol; 2015 Jun; 20(4):473-89. PubMed ID: 24490793 [TBL] [Abstract][Full Text] [Related]
27. Effect of lecithin on epicutaneous absorption of diclofenac epolamine. Conte A; Ronca G; Petrini M; Mautone G Drugs Exp Clin Res; 2002; 28(6):249-55. PubMed ID: 12776579 [TBL] [Abstract][Full Text] [Related]
28. Transdermal delivery of diclofenac using water-in-oil microemulsion: formulation and mechanistic approach of drug skin permeation. Thakkar PJ; Madan P; Lin S Pharm Dev Technol; 2014 May; 19(3):373-84. PubMed ID: 23634780 [TBL] [Abstract][Full Text] [Related]
30. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems. Sintov AC; Botner S Int J Pharm; 2006 Mar; 311(1-2):55-62. PubMed ID: 16431047 [TBL] [Abstract][Full Text] [Related]
31. Diclofenac Loaded Lipid Nanovesicles Prepared by Double Solvent Displacement for Skin Drug Delivery. Sala M; Locher F; Bonvallet M; Agusti G; Elaissari A; Fessi H Pharm Res; 2017 Sep; 34(9):1908-1924. PubMed ID: 28631206 [TBL] [Abstract][Full Text] [Related]
32. Prediction of Human Pharmacokinetic Profile After Transdermal Drug Application Using Excised Human Skin. Yamamoto S; Karashima M; Arai Y; Tohyama K; Amano N J Pharm Sci; 2017 Sep; 106(9):2787-2794. PubMed ID: 28315690 [TBL] [Abstract][Full Text] [Related]
33. Dermatopharmacokinetics of salicylate following topical injection in rats: effect of osmotic pressure and injection volume on salicylate disposition. Yoshida D; Todo H; Hasegawa T; Sugibayashi K Int J Pharm; 2007 Jun; 337(1-2):142-7. PubMed ID: 17280809 [TBL] [Abstract][Full Text] [Related]
34. Bioequivalence of diclofenac sodium 2% and 1.5% topical solutions relative to oral diclofenac sodium in healthy volunteers. Holt RJ; Taiwo T; Kent JD Postgrad Med; 2015 Aug; 127(6):581-90. PubMed ID: 26077436 [TBL] [Abstract][Full Text] [Related]
35. In Silico Modelling of Transdermal and Systemic Kinetics of Topically Applied Solutes: Model Development and Initial Validation for Transdermal Nicotine. Chen T; Lian G; Kattou P Pharm Res; 2016 Jul; 33(7):1602-14. PubMed ID: 26956458 [TBL] [Abstract][Full Text] [Related]
36. Use of minipig skin biopsy model as an innovative tool to design topical formulation to achieve desired pharmacokinetics in humans. Mitra A; Leyes A; Manser K; Roadcap B; Mestre C; Tatosian D; Jin L; Uemura N J Pharm Sci; 2015 May; 104(5):1701-8. PubMed ID: 25691117 [TBL] [Abstract][Full Text] [Related]
37. Ceramide-2 nanovesicles for effective transdermal delivery: development, characterization and pharmacokinetic evaluation. Gaur PK; Purohit S; Kumar Y; Mishra S; Bhandari A Drug Dev Ind Pharm; 2014 Apr; 40(4):568-76. PubMed ID: 23547761 [TBL] [Abstract][Full Text] [Related]
38. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Manosroi A; Jantrawut P; Manosroi J Int J Pharm; 2008 Aug; 360(1-2):156-63. PubMed ID: 18539416 [TBL] [Abstract][Full Text] [Related]
39. Surfactant effects on the in vitro percutaneous absorption of diclofenac sodium. Arellano A; Santoyo S; Martn C; Ygartua P Eur J Drug Metab Pharmacokinet; 1998; 23(2):307-12. PubMed ID: 9725498 [TBL] [Abstract][Full Text] [Related]
40. Permeation study through bacterial cellulose membrane. Wu C; Murtaza G; Yameen MA; Aamir MN; Akhtar M; Zhao Y Acta Pol Pharm; 2014; 71(2):297-300. PubMed ID: 25272650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]